Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (36)

« Back to Publications

Response to Comments on 'Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines'.

Campbell C. et al, (2026), J Viral Hepat, 33

Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines.

Campbell C. et al, (2025), J Viral Hepat, 32

Can large language models replace standardised patients?

Han W. et al, (2025), Med Educ, 59, 552 - 553

Liver, cardiovascular and metabolic factors as predictors of all-cause mortality in a rural Ugandan Cohort

Campbell C. et al, (2025)

Reply to: "Understanding virologic heterogeneity in chronic hepatitis B treatment".

Matthews PC. et al, (2025), JHEP Rep, 7

Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapy.

Wang T. et al, (2025), JHEP Rep, 7

Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapy

Wang T. et al, (2025), JHEP Reports, 7, 101229 - 101229

Hepatitis B Virus (HBV) treatment eligibility in the UK: retrospective longitudinal cohort data to explore the impact of changes in clinical guidelines

Campbell C. et al, (2024)

Evaluation of Hepatitis B core related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South Africa

Downs LO. et al, (2024)

Classification of virologic trajectories during nucleos/tide analogue treatment of hepatitis B virus (HBV) infection

Wang T. et al, (2023)

Cohort Profile: The National Institute for Health Research Health Informatics Collaborative: Hepatitis B Virus (NIHR HIC HBV) research dataset.

Wang T. et al, (2023), Int J Epidemiol, 52, e27 - e37

Bone mineral density and fractures in patients with rheumatoid arthritis: the DXA-HIP project.

Ebrahimiarjestan M. et al, (2023), Rheumatol Adv Pract, 7

Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?

Campbell C. et al, (2023), Wellcome Open Research, 7

Analysis of electronic health record data of hepatitis B virus (HBV) patients in primary care: hepatocellular carcinoma (HCC) risk associated with socioeconomic deprivation and reduced by statins

Campbell C. et al, (2022)

Identifying Hepatocellular Carcinoma from imaging reports using natural language processing to facilitate data extraction from electronic patient records

Wang T. et al, (2022)

Load More